Equities Analysts Offer Predictions for DMAC Q1 Earnings
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of DiaMedica Therapeutics in a report released on Wednesday, March 19th. HC Wainwright analyst M. Caufield expects that the company will post earnings of ($0.18) per share for the quarter. HC Wainwright has a […]
